Metacrine Presents Positive MET409 Phase 1b Clinical Data in NASH Patients at the Digital International Liver Congress™ 2020

Press/Media: Press / Media

PeriodAug 27 2020 → Aug 28 2020

Media coverage

14

Media coverage

  • TitleMetacrine Presents Positive MET409 Phase 1b Clinical Data in NASH Patients at the Digital International Liver Congress™ 2020
    Media name/outletPipelineReview
    CountrySpain
    Date8/28/20
    PersonsEric J Lawitz
  • TitleMetacrine Presents Positive MET409 Phase 1b Clinical Data in NASH Patients at the Digital International Liver Congress™ 2020
    Media name/outletBioSpace
    CountryUnited States
    Date8/28/20
    PersonsEric J Lawitz
  • TitleMetacrine Presents Positive MET409 Phase 1b Clinical Data in NASH Patients at the Digital International Liver Congress™ 2020
    Media name/outletMorningstar.com
    CountryUnited States
    Date8/27/20
    PersonsEric J Lawitz
  • TitleMetacrine Presents Positive MET409 Phase 1b Clinical Data in NASH Patients at the Digital International Liver Congress™ 2020
    Media name/outletMarketScreener.com
    CountryUnited States
    Date8/27/20
    PersonsEric J Lawitz
  • TitleMetacrine Presents Positive MET409 Phase 1b Clinical Data in NASH Patients at the Digital International Liver Congress™ 2020
    Media name/outletMarket Newsdesk
    CountryUnited States
    Date8/27/20
    PersonsEric J Lawitz
  • TitleMetacrine Presents Positive MET409 Phase 1b Clinical Data in NASH Patients at the Digital International Liver Congress™ 2020
    Media name/outletMarkets Business Insider
    CountryUnited States
    Date8/27/20
    PersonsEric J Lawitz
  • TitleMetacrine Presents Positive MET409 Phase 1b Clinical Data in NASH Patients at the Digital International Liver Congress™ 2020
    Media name/outletSpoke.com
    CountryUnited States
    Date8/27/20
    PersonsEric J Lawitz
  • TitleMetacrine Presents Positive MET409 Phase 1b Clinical Data in NASH Patients at the Digital International Liver Congress™ 2020
    Media name/outletValuespectrum.com
    CountryUnited States
    Date8/27/20
    PersonsEric J Lawitz
  • TitleMetacrine Presents Positive MET409 Phase 1b Clinical Data in NASH Patients at the Digital International Liver Congress™ 2020
    Media name/outletJotup
    CountryUnited States
    Date8/27/20
    PersonsEric J Lawitz
  • TitleMetacrine Presents Positive MET409 Phase 1b Clinical Data in NASH Patients at the Digital International Liver Congress™ 2020
    Media name/outletUSA Life Sciences Database
    CountrySwitzerland
    Date8/27/20
    PersonsEric J Lawitz
  • TitleMetacrine Presents Positive MET409 Phase 1b Clinical Data in NASH Patients at the Digital International Liver Congress™ 2020
    Media name/outletBiotechgate
    CountrySwitzerland
    Date8/27/20
    PersonsEric J Lawitz
  • TitleMetacrine Presents Positive MET409 Phase 1b Clinical Data in NASH Patients at the Digital International Liver Congress™ 2020
    Media name/outletGlobeNewswire
    CountryUnited States
    Date8/27/20
    PersonsEric J Lawitz
  • TitleMetacrine Presents Positive MET409 Phase 1b Clinical Data in NASH Patients at the Digital International Liver Congress™ 2020
    Media name/outletBizWire Express
    CountryIndia
    Date8/27/20
    PersonsEric J Lawitz
  • TitleMetacrine Presents Positive MET409 Phase 1b Clinical Data in NASH Patients at the Digital International Liver Congress„¢ 2020; MET409 demonstrated notable improvements in decreased liver fat content and differentiated impacts on pruritus and LDL cholester
    Media name/outletPrimeNewswire (Top News)
    CountryUnited States
    Date8/27/20
    PersonsEric J Lawitz